+30.4%
GSK vs ALLE
-5.8%
+36.3%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ALLE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | +1.0% | -2.9% | -2.1% |
| 7D | -1.8% | -0.2% | -1.6% | -1.8% |
| 30D | -2.2% | -6.8% | +4.6% | -1.0% |
| 3M | -1.8% | +21.0% | -22.8% | -5.4% |
| 6M | -10.6% | +1.1% | -11.7% | -11.1% |
| YTD | +4.4% | -0.5% | +5.0% | +2.3% |
| 1Y | +30.4% | -7.3% | +37.7% | +28.0% |
| All | +30.4% | -5.8% | +36.3% | +28.0% |
Cumulative growth
Daily Returns
Daily percentage return beside ALLE.
Daily Out/Under-Performance
Portfolio return minus ALLE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALLE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ALLE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling